PRKCA and B-cell chronic lymphocytic leukemia: We and others have previously demonstrated that PKCβII is upregulated in CLL mouse models (Eμ-Tcl-1 and PKCα-KR; [12]) and in primary CLL samples, particularly in poor prognostic samples suggesting a role in CLL pathogenesis [8].